Revised forecast
Fiscal year ending June 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Total extraordinary losses: ¥98 million (impairment loss: ¥1 million; litigation-related expenses: ¥35 million; inventory valuation loss: ¥60 million; loss on retirement of fixed assets: ¥0 million; other: ¥0 million)
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥14,100 million |
| Operating profit | Not disclosed → ¥960 million |
| Ordinary income | Not disclosed → ¥840 million |
| Profit attributable to owners of the parent | Not disclosed → ¥710 million |
| Fiscal Period Covered | Fiscal year ending June 2027 |
| Period Covered | Full year |
| Previous-period results | Net sales: ¥12,877 million; operating income: ¥567 million; ordinary income: ¥436 million; net income attributable to owners of the parent: ¥818 million (fiscal year ended June 2026) |
| Details and amount of extraordinary loss | Total extraordinary losses: ¥98 million (impairment loss: ¥1 million; litigation-related expenses: ¥35 million; inventory valuation loss: ¥60 million; loss on retirement of fixed assets: ¥0 million; other: ¥0 million) |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company kept sales volume in check by expanding high-margin products and optimizing sales channels, while improving profitability through improvements in procurement and inventory management, the cost ratio and logistics expenses. In addition, optimization of tax costs through a reduction in capital and the additional recognition of deferred tax assets increased net income.